Search
asunaprevir
Indications:
- treatment of refractory hepatitis C, including those with HCV genotype 1 infection [1]
Dosage:
- 600 mg BID
Mechanism of action:
- NS3 protease inhibitor
General
antiviral protease inhibitor
Database Correlations
PUBCHEM cid=16076883
References
- Lok AS et al.
Preliminary study of two antiviral agents for hepatitis C
genotype 1.
N Engl J Med 2012 Jan 19; 366:216.
PMID: 22256805
- Chung RT.
A watershed moment in the treatment of hepatitis C.
N Engl J Med 2012 Jan 19; 366:273.
PMID: 22256811